Table 1.
Serial | Age | Sex | HBsAg | HIV | ALT(Normal | AST(Normal | ALP(Normal | GGT(Normal | AFP(Normal | Histopathology | Status at 1 month |
No | serology | </=40 | </=32 | </=129 | </=65 | </=8 | type | ||||
IU/ml) | IU/ml) | IU/ml) | IU/ml) | IU/ml) | |||||||
1 | 38 | F | P | N | 43 | 549 | 165 | 457 | 400 | Trabecular | A |
2 | 18 | F | P | N | 46 | 46 | 356 | 248 | 326 | Trabecular | D |
3 | 28 | M | P | N | 54 | 119 | 1294 | 365 | 400 | X | A |
4 | 19 | M | P | N | 87 | 321 | 346 | 535 | 400 | Trabecular | D |
5 | 15 | M | P | N | 130 | 100 | 392 | 250 | 362 | Trabecular | D |
6 | 26 | M | P | N | 105 | 307 | 601 | 315 | 400 | Trabecular | A |
7 | 43 | F | P | N | 74 | 332 | 449 | 633 | 326 | Trabecular | D |
8 | 33 | F | P | P | 79 | 222 | 1043 | 312 | 400 | X | A |
9 | 30 | F | N | N | 14 | 96 | 680 | 413 | 400 | Trabecular | D |
10 | 38 | M | P | N | 51 | 270 | 294 | 122 | 362 | Trabecular | D |
11 | 36 | M | P | P | 145 | 393 | 930 | 484 | 7 | Trabecular | D |
12 | 38 | M | N | N | 55 | 136 | * | 268 | 338 | Fibrolamellar | D |
13 | 45 | F | P | P | 60 | 40 | 120 | 60 | 480 | X | D |
14 | 33 | M | P | N | 60 | 275 | * | 192 | 400 | Adenoid | D |
15 | 67 | M | P | N | 18 | 88 | 349 | 226 | 350 | X | D |
M-Male, F- Female, P- positive, N- negative, X- Biopsy not done, D-Dead, A-Alive, ALT- Alanine aminotransferase, ALP- Alkaline phosphatase, AST Aspartate aminotransferase, GGT- Gamma glutamyltraspeptidase, AFP- Alpha-fetoprotein, HBsAg- Hepatitis B surface antigen, HIV- Human immune deficiency virus
Patients in whom ALP measurements were missing